REPL vs WST · $825.7M cap vs P/E 35, rev $2.89B
Replimune Group Inc (REPL) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
REPL does not have a complete income-statement cache yet.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
REPL currently screens at market cap $825.7M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the REPL and WST stock pages for the full models.
Not investment advice.